Hanesbrands (HBI) PT Lowered to $16 at Credit Suisse
Tweet
Share
E-mailGet Alerts HBI Hot Sheet
Price: $6.47 --0%
Rating Summary:
9 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
9 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Michael Binetti lowered the price target on Hanesbrands (NYSE: HBI) to $16.00 (from $19.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Giant Biogene Holding Co (2367:HK) PT Raised to HK$46 at Macquarie
- Analog Devices (ADI) PT Raised to $500 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
